We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Illustration of two therapeutic antibodies (blue) binding to receptors on a cell membrane (orange), blocking cellular pathways.

Monitor Protein Therapeutic Color Changes With LC-MS


Want to share this FREE webinar with a colleague?

Fill out the form below and we'll send your colleague an invitation to the "Monitor Protein Therapeutic Color Changes With LC-MS" event.

The color of a therapeutic monoclonal antibody solution is a critical quality attribute (CQA), essential for maintaining consistency throughout clinical trials and commercial production. 


Color changes are often associated with advanced glycation end products (AGEs), which form as post-translational modifications (PTMs). Monitoring these changes is essential, as they can impact both the efficacy and safety of the final drug product.


This webinar explores the implementation of a liquid chromatography-mass spectrometry (LC-MS) workflow for peptide mapping to investigate and track these PTMs.


Watch this webinar to explore:

    • Key product quality attributes associated with color changes in therapeutics
    • The connection between AGEs and color variation
    • The use of LC-MS to quantitatively monitor AGEs in drug development
    Keynote Speaker
    A picture of Andrew D. Mahan, PhD
    Andrew D. Mahan, PhD
    Mass Spec Group Leader, Cell Engineering and Analytical Sciences
    J&J Innovative Medicines
    Brought to you by

    Have a question about our online events and webinars? Get in touch here.
    Now Available on Demand!
    Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
    Want to invite a colleague?

    Click the button below to begin inviting a colleague to this Webinar